Ohimachi, Japan

Shigeo Hatanaka

This inventor holds 3 USPTO granted patents. Top assignee: Nisshin Flour Milling Co., Ltd.. Active years: 1997-1998.


% Patents Active = 100.0

Average Co-Inventor Count = 4.6

ph-index = 2

Forward Citations = 7(Granted Patents)


Location History:

  • Ohimachi, JP (1997 - 1998)
  • Saitama-ken, JP (1998)

Company Filing History:


Years Active: 1997-1998

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Shigeo Hatanaka: Innovator in Pharmaceutical Development

Introduction

Shigeo Hatanaka is a notable inventor based in Ohimachi, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of treatments for various diseases. With a total of 3 patents to his name, Hatanaka's work has the potential to impact many lives.

Latest Patents

Hatanaka's latest patents include innovative compounds that address critical health issues. One of his notable inventions is a cyclic depsipeptide useful for the treatment of hyperlipemia. Additionally, he has developed agents for inhibiting the production of IL-1.beta. and the release of TNF.alpha. These pharmaceutical applications of 1-cinnamoyl-2-pyrrolidinone derivatives are particularly promising for the treatment or prophylaxis of chronic rheumatism and sepsis.

Career Highlights

Hatanaka is currently employed at Nisshin Flour Milling Co., Ltd., where he continues to advance his research and development efforts. His work at this company has allowed him to focus on creating effective pharmaceutical solutions that can improve patient outcomes.

Collaborations

Throughout his career, Hatanaka has collaborated with esteemed colleagues such as Yukio Saito and Koichi Katsuyama. These partnerships have fostered a collaborative environment that enhances innovation and drives progress in their shared field.

Conclusion

Shigeo Hatanaka's contributions to pharmaceutical innovation are noteworthy and demonstrate his commitment to improving health outcomes. His patents reflect a dedication to addressing significant medical challenges, and his work continues to inspire advancements in the industry.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…